Obstetric Labor Complications
2
Pipeline Programs
3
Companies
4
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Oregon TherapeuticsFrance - Paris
2 programs2
Ferric derisomaltosePhase 11 trial
Intrauterine pressure catheterPhase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
Oregon TherapeuticsFerric derisomaltose
Oregon TherapeuticsIntrauterine pressure catheter
LundbeckThe PartoMa intervention
Impact TherapeuticsExperimental: Treatment 1
Clinical Trials (4)
Total enrollment: 18,257 patients across 4 trials
Monoferric for Prenatal Iron Deficiency
Start: Jan 2024Est. completion: Oct 202880 patients
Phase 1Recruiting
Amniotic Fluid Analysis
Start: Nov 2023Est. completion: Jun 2024100 patients
Phase 1Unknown
The PartoMa Project: For Improving Monitoring, Action and Triage During Labour
Start: Oct 2014Est. completion: Jul 20183,087 patients
N/ACompleted
Improving Maternal and Child Health in India: Evaluating Demand and Supply Side Strategies (IMATCHINE)
Start: Aug 2012Est. completion: Nov 201514,990 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 18,257 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.